Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Patient Related Outcome Measures|June 19, 2023
Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research NetworksTimothy Beukelman, Millie D Long, Rennie L Rhee, et al.Arthritis Care & Research|February 1, 2012
Consensus treatment plans for new-onset systemic juvenile idiopathic arthritisEsi Morgan DeWitt, Yukiko Kimura, Timothy Beukelman, et al.JAMA|November 8, 2011
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseasesCarlos G Grijalva, Lang Chen, Elizabeth Delzell, et al.Arthritis Care & Research|May 29, 2018
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior UveitisSheila T Angeles-Han, Mindy S Lo, Lauren A Henderson, et al.Pediatric Rheumatology Online Journal|April 13, 2017
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment PlansYukiko Kimura, Sriharsha Grevich, Timothy Beukelman, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2020
New Medications Are Needed for Children With Juvenile Idiopathic ArthritisHermine I Brunner, Laura E Schanberg, Yukiko Kimura, et al.Pharmacoepidemiology and Drug Safety|September 16, 2011
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systemsLisa J Herrinton, Jeffrey R Curtis, Lang Chen, et al.Pediatric Rheumatology Online Journal|April 21, 2017
A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunitiesTimothy Beukelman, Janneke Anink, Lillemor Berntson, et al.American Journal of Ophthalmology|September 13, 2012
Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) StudyKevin L Winthrop, Lang Chen, Frederick W Fraunfelder, et al.Contemporary Clinical Trials|July 17, 2012
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesKenneth G Saag, Penny E Mohr, Laura Esmail, et al.Pageof 13